ROMJ Stock Overview
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Rubicon Organics Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.52 |
52 Week High | CA$0.55 |
52 Week Low | CA$0.29 |
Beta | 0.85 |
1 Month Change | 33.33% |
3 Month Change | 15.56% |
1 Year Change | 20.93% |
3 Year Change | -60.00% |
5 Year Change | -68.48% |
Change since IPO | -84.00% |
Recent News & Updates
Investors Still Aren't Entirely Convinced By Rubicon Organics Inc.'s (CVE:ROMJ) Revenues Despite 37% Price Jump
Mar 22Is Rubicon Organics (CVE:ROMJ) Using Debt Sensibly?
Mar 14Slammed 30% Rubicon Organics Inc. (CVE:ROMJ) Screens Well Here But There Might Be A Catch
Feb 05Recent updates
Investors Still Aren't Entirely Convinced By Rubicon Organics Inc.'s (CVE:ROMJ) Revenues Despite 37% Price Jump
Mar 22Is Rubicon Organics (CVE:ROMJ) Using Debt Sensibly?
Mar 14Slammed 30% Rubicon Organics Inc. (CVE:ROMJ) Screens Well Here But There Might Be A Catch
Feb 05A Piece Of The Puzzle Missing From Rubicon Organics Inc.'s (CVE:ROMJ) 26% Share Price Climb
Dec 22Health Check: How Prudently Does Rubicon Organics (CVE:ROMJ) Use Debt?
Sep 25Rubicon Organics Inc. (CVE:ROMJ) Soars 27% But It's A Story Of Risk Vs Reward
Jun 08Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)
May 06Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
Mar 07Is Rubicon Organics (CVE:ROMJ) A Risky Investment?
Sep 28Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet
Jun 13Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?
Jun 06Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?
Jan 09Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt
Sep 19Shareholder Returns
ROMJ | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 2.0% | -0.9% | 1.5% |
1Y | 20.9% | -59.4% | 10.8% |
Return vs Industry: ROMJ exceeded the Canadian Pharmaceuticals industry which returned -59.4% over the past year.
Return vs Market: ROMJ exceeded the Canadian Market which returned 10.8% over the past year.
Price Volatility
ROMJ volatility | |
---|---|
ROMJ Average Weekly Movement | 13.2% |
Pharmaceuticals Industry Average Movement | 11.9% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 3.3% |
Stable Share Price: ROMJ's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: ROMJ's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 181 | Margaret Brodie | www.rubiconorganics.com |
Rubicon Organics Inc., together with its subsidiaries, engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada. It offers cannabis products in jar, bag, pre-rolls, edible, poutine sauce mix, milled flower, relief stick, cool stick, and oil. The company sells its products under the Simply Bare Organic, 1964 Supply Co, Homestead Cannabis Supply, LAB THEORY, and Wildflower brand names.
Rubicon Organics Inc. Fundamentals Summary
ROMJ fundamental statistics | |
---|---|
Market cap | CA$29.39m |
Earnings (TTM) | -CA$2.01m |
Revenue (TTM) | CA$44.49m |
0.7x
P/S Ratio-14.7x
P/E RatioIs ROMJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ROMJ income statement (TTM) | |
---|---|
Revenue | CA$44.49m |
Cost of Revenue | CA$30.16m |
Gross Profit | CA$14.33m |
Other Expenses | CA$16.34m |
Earnings | -CA$2.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 01, 2025
Earnings per share (EPS) | -0.035 |
Gross Margin | 32.21% |
Net Profit Margin | -4.51% |
Debt/Equity Ratio | 29.6% |
How did ROMJ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/23 01:50 |
End of Day Share Price | 2025/03/21 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Rubicon Organics Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kimberly Thompson-Hedlin | Canaccord Genuity |
Colin Healey | Haywood Securities Inc. |
Neal Gilmer | Haywood Securities Inc. |